VIVS
VIVS
NASDAQ · Biotechnology

Vivosim Labs Inc

$1.62
-0.07 (-4.14%)
As of Mar 29, 11:01 PM ET ·
Analyst Consensus
Strong Sell
7
Analysts
Moderate
Coverage
Buy 0 0%
Hold 4 57%
Sell 3 43%
Price Target
Analyst Price Target +1,667.3% upside
Low Target $25.08
Average Target $28.63
High Target $44.18
Current Price $1.62
Current
$1.62
Target
$28.63
$25.08 $28.63 avg $44.18
Scenario Analysis
Bear Case
$25.08
1,448.1%
Low target
Base Case
$28.63
+1,667.3%
Avg target
Bull Case
$44.18
+2,627.2%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$5.30
-69.4% from high
52-Week Low
$1.41
+14.9% from low
Target vs 52W High
$28.63
+440.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +18.4%
AMGN
Amgen Inc
Hold 42 50% $190.87 -45.8%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +160.2%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -1.8%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -69.1%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -12.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -28.5%